Congress Asset Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$960K Buy
275,158
+46,466
+20% +$206K 0.01% 328
2026
Q2
$1.24M Buy
228,692
+2,414
+1% +$9.26K 0.01% 297
2026
Q1
$516K Buy
226,278
+32,621
+17% +$103K ﹤0.01% 376
2025
Q4
$775K Buy
193,657
+5,300
+3% +$29.5K 0.01% 326
2025
Q3
$1.59M Buy
188,357
+595
+0.3% +$5.77K 0.01% 298
2025
Q2
$2.11M Sell
187,762
-140
-0.1% -$1.29K 0.01% 282
2025
Q1
$1.78M Sell
187,902
-36,382
-16% -$368K 0.01% 280
2024
Q4
$2.52M Buy
224,284
+120,261
+116% +$2.11M 0.02% 270
2024
Q3
$2.94M Sell
104,023
-906
-0.9% -$23.4K 0.02% 257
2024
Q2
$2.01M Buy
+104,929
New +$2.68M 0.01% 280

Other funds holding EVH

Congress Asset Management's EVH Position: Q3 2026 in Review

Congress Asset Management increased its Evolent Health (EVH) stake by 20% in Q3 2026, buying an estimated $206K and bringing the position to 275,158 shares worth $960K. The position accounts for 0.01% of the portfolio, ranked #328.

Congress Asset Management first reported a position in EVH in Q2 2024 and has held it in 10 quarters since. The position peaked at $2.94M in Q3 2024. 4 funds tracked by Wall St. Rank hold EVH as of Q3 2026.

  • Congress Asset Management held 275,158 shares of Evolent Health worth $960K as of Q3 2026.
  • Congress Asset Management bought 46,466 Evolent Health shares in Q3 2026, an estimated $206K.
  • Evolent Health made up 0.01% of Congress Asset Management's portfolio in Q3 2026, its #328 holding.
  • Congress Asset Management first reported a position in Evolent Health in Q2 2024 and has held it in 10 quarters since.
  • Congress Asset Management's Evolent Health position peaked at $2.94M in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Evolent Health as of Q3 2026.

Based on Congress Asset Management's 13F filing for Q3 2026, filed 6 Oct 2026.